Category: Health & Medicines > Medicines > Bulk Drugs
Country/Region: China State/Province: Jiangsu
Main Products: Moxifloxacin, Esomeprazole, Roflumilast, Rocuronium Bromide
Business Type: Exporter, Retailer
Year Established: 2004
Employees: 11 - 50 People
Plant Area: 50,000-100,000 square meters
Main Markets: South America 9% Africa 10% Eastern Asia 8% Domestic Market 11% North America 8% Eastern Europe 10% Southern Europe 9% Mid East 12% Northern Europe 9% Oceania 14%
Trade Capacity: FOB, CFR, DAF
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Nanjing
Annual Revenue: US$5 Million - US$10 Million
Total Revenue: US$10 Million - US$50 Million
Export Revenue: US$1 Million - US$2.5 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: Below US$1 Million
Export Percentage: 91% - 100%
Payment Modes: USD, EUR, CHF
Lead Time: 35 days
Import/Export Mode: Using an agent